LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

SHE:002644 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	386.34	397.89	406.04	397.85	374.94	419.96
Trading Asset Securities	-	-	-	2	-	32.08
Cash & Short-Term Investments	386.34	397.89	406.04	399.85	374.94	452.04
Cash Growth	5.75%	-2.01%	1.55%	6.64%	-17.06%	4.00%
Accounts Receivable	416.95	413.57	382.65	435.88	344.8	313.31
Other Receivables	26.05	32.21	42.64	62.98	12.34	4.58
Receivables	443	445.78	425.29	498.87	357.14	317.89
Inventory	313.46	339.99	369.72	363.26	258.83	258.33
Other Current Assets	36.13	38.22	37.82	42	43.72	25.89
Total Current Assets	1,179	1,222	1,239	1,304	1,035	1,054
Property, Plant & Equipment	1,028	1,032	1,062	1,068	1,092	1,110
Long-Term Investments	54.5	55.66	64.1	68.67	71.65	73.6
Goodwill	9.01	9.01	9.01	9.01	4.47	4.47
Other Intangible Assets	76.07	76.87	79.55	76.79	71.96	74.01
Long-Term Deferred Tax Assets	62.86	61.81	53.65	53.98	51.11	51.31
Long-Term Deferred Charges	1.63	3.76	7.65	6	0.89	0.27
Other Long-Term Assets	9.59	8.78	13.43	20.41	25.76	18.93
Total Assets	2,421	2,470	2,528	2,606	2,352	2,387
Accounts Payable	191.73	213.09	310.37	314.47	214.3	300.21
Accrued Expenses	1.36	2.07	11.46	28.86	9.9	9.98
Short-Term Debt	10	10	10	-	-	19.62
Current Portion of Long-Term Debt	13.44	14.74	13.89	13.4	14.2	14.36
Current Portion of Leases	-	-	0.8	0.87	0.5	-
Current Income Taxes Payable	31.74	27.62	27.42	44.74	44.26	47.14
Current Unearned Revenue	24.94	16.05	47.02	99.93	35.91	9.1
Other Current Liabilities	51.57	96.15	46.74	40.28	55.78	22.03
Total Current Liabilities	324.79	379.73	467.69	542.54	374.84	422.44
Long-Term Debt	3.8	1.8	26.6	40.37	53.14	66.55
Long-Term Leases	1.23	1.05	1.35	0.97	0.81	-
Long-Term Unearned Revenue	252.49	256.1	260.96	278.15	294.96	310.21
Long-Term Deferred Tax Liabilities	3.37	2.93	3.07	3.18	0.85	0.88
Other Long-Term Liabilities	-	13.2	-	-	-	-
Total Liabilities	585.67	654.81	759.67	865.21	724.59	800.08
Common Stock	510.66	510.66	510.66	510.66	510.66	510.66
Additional Paid-In Capital	337.39	337.39	337.38	352.33	343.51	343.01
Retained Earnings	960.26	940.88	896.13	854.47	758.78	726.8
Comprehensive Income & Other	0.96	0.96	1.21	1.6	1.62	1.62
Total Common Equity	1,809	1,790	1,745	1,719	1,615	1,582
Minority Interest	25.83	25.09	23.06	22.17	12.92	5.01
Shareholders' Equity	1,835	1,815	1,768	1,741	1,628	1,587
Total Liabilities & Equity	2,421	2,470	2,528	2,606	2,352	2,387
Total Debt	28.47	27.59	52.63	55.6	68.65	100.54
Net Cash (Debt)	357.87	370.3	353.41	344.26	306.29	351.5
Net Cash Growth	9.77%	4.78%	2.66%	12.39%	-12.86%	3.33%
Net Cash Per Share	0.70	0.72	0.69	0.67	0.60	0.69
Filing Date Shares Outstanding	510.04	510.92	510.66	510.66	510.66	510.66
Total Common Shares Outstanding	510.04	510.92	510.66	510.66	510.66	510.66
Working Capital	854.14	842.16	771.18	761.43	659.79	631.71
Book Value Per Share	3.55	3.50	3.42	3.37	3.16	3.10
Tangible Book Value	1,724	1,704	1,657	1,633	1,538	1,504
Tangible Book Value Per Share	3.38	3.34	3.24	3.20	3.01	2.94
Buildings	-	-	938.67	933.74	927.81	906.76
Machinery	-	-	366.31	333.01	317.82	311.68
Construction In Progress	-	-	3.3	-	-	3.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.